Skip to main content
SpringerLink
Log in

How Many Breast Cancer Cells in a Sentinel Lymph Node are OK?

  • Editorials
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565.

    Google Scholar 

  2. Cote RJ. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 1999;354:896.

    Article  CAS  PubMed  Google Scholar 

  3. Greene F. AJCC Cancer Staging Manual New York: Springer-Verlag, 2002

    Google Scholar 

  4. Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001;20:230.

    Article  CAS  PubMed  Google Scholar 

  5. Krag DN. Radiolabeled sentinel node biopsy: collaborative trial with the national cancer institute. World J Surg 2001;25:823.

    Google Scholar 

  6. Frkovic-Grazio, Susnik, S, Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage 1 breast cancer: a case-control study with 15 year follow-up. Ann Surg Oncol 2004;11:568–72.

    Google Scholar 

  7. Carter BA. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000;113:259.

    Google Scholar 

  8. Page DL, Anderson TJ, Carter BA. Minimal solid tumor involvement of regional and distant sites: when is a metastasis not a metastasis?. Cancer 1999;86:2589.

    Google Scholar 

  9. Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG, McGuckin MA. Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol 2002;26:1286–95.

    Google Scholar 

  10. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Cancer 1996;73:88–95.

    Google Scholar 

  11. Nasser IA, Lee AK, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in “node-negative” breast carcinoma. Hum Pathol 1993;24:950–7.

    Article  CAS  PubMed  Google Scholar 

  12. Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer 2002;86:396–401.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Yale New Haven Breast Center, New Haven, Connecticut

    Donald R. Lannin MD

  2. Department of Surgery, Yale New Haven Breast Center, 800 Howard Avenue, Lower Level 38, New Haven, Connecticut, 06510

    Donald R. Lannin MD

Authors
  1. Donald R. Lannin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald R. Lannin MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lannin, D.R. How Many Breast Cancer Cells in a Sentinel Lymph Node are OK?. Ann Surg Oncol 11, 553–554 (2004). https://doi.org/10.1245/ASO.2004.04.908

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2004.04.908

Search

Navigation